Prasugrel (Maleic acid) is used as an antiplatelet agent; it acts as a potent P2Y12 receptor antagonist to inhibit ADP-induced platelet aggregation, thereby preventing thrombotic events in patients with acute coronary syndromes or undergoing percutaneous coronary intervention.